日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus

贝利木单抗在系统性红斑狼疮患者中的区域间药代动力学和暴露-反应分析

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.16263
Wu, Junyi; Zhou, Xuan; Dimelow, Richard; Marshall, Scott
红斑狼疮
免疫/内分泌
发表日期：2025
文献求助 收藏

Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus

贝利木单抗对系统性红斑狼疮患者记忆B细胞迁移的干扰

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keae286
Arends, Eline J; Zlei, Mihaela; Tipton, Christopher M; Cotic, Jasna; Osmani, Zgjim; de Bie, Fenna J; Kamerling, Sylvia W A; van Maurik, Andre; Dimelow, Richard; Gregan, Yun Irene; Fox, Norma Lynn; Rabelink, Ton J; Roth, David A; Sanz, Ignacio; van Dongen, Jacques J M; van Kooten, Cees; Teng, Y K Onno
B细胞
细胞生物学
红斑狼疮
免疫/内分泌
发表日期：2024
文献求助 收藏

Extrapolation of the Efficacy and Pharmacokinetics of Belimumab to Support its Use in Children with Lupus Nephritis

贝利木单抗疗效和药代动力学的外推以支持其在儿童狼疮性肾炎中的应用

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-024-01422-y
Dimelow, Richard; Liefaard, Lia; Green, Yulia; Tomlinson, Ryan
肾炎
发表日期：2024
文献求助 收藏

Population model-based analysis of the memory B-cell response following belimumab therapy in the treatment of systemic lupus erythematosus

基于群体模型的贝利木单抗治疗系统性红斑狼疮后记忆B细胞反应分析

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12919
Dimelow, Richard; Gillespie, William R; van Maurik, Andre
B细胞
细胞生物学
红斑狼疮
免疫/内分泌
发表日期：2023
文献求助 收藏

The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study

贝利尤单抗治疗停用24周后重新开始治疗对系统性红斑狼疮（SLE）患者的影响：一项开放标签、非随机、为期52周的研究

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-022-02723-y
Bae, Sang-Cheol; Bass, Damon L; Chu, Myron; Curtis, Paula; Dimelow, Richard; Harvey, Laurence; Ji, Beulah; Kurrasch, Regina; Muzaffar, Saima; Punwaney, Raj; Roth, David A; Song, Yeong-Wook; Xie, Wendy; Zhang, Fengchun
红斑狼疮
免疫/内分泌
发表日期：2022
文献求助 收藏

Balancing patients' fears of recurrence and fears of COVID-19 when considering their preference for review consultations

在考虑患者对复诊咨询的偏好时，要平衡他们对疾病复发的恐惧和对新冠肺炎的恐惧。

期刊:European Archives of Oto-Rhino-Laryngology
影响因子:2.2
doi:10.1007/s00405-021-06662-3
Dimelow, Joanna; Lowe, Derek; Rogers, Simon N
肺炎
新冠
微生物学
发表日期：2021
文献求助 收藏

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus

贝利木单抗在系统性红斑狼疮患儿中的药代动力学

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.889
Dimelow, Richard; Ji, Beulah; Struemper, Herbert
红斑狼疮
免疫/内分泌
发表日期：2021
文献求助 收藏

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

健康志愿者血浆和上皮衬液中头孢他啶和阿维巴坦的群体药代动力学模型

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-018-0241-0
Dimelow, Richard; Wright, James G; MacPherson, Merran; Newell, Paul; Das, Shampa
发表日期：2018
文献求助 收藏

Control of translation initiation: a model-based analysis from limited experimental data

翻译起始的控制：基于有限实验数据的模型分析

期刊:Journal of the Royal Society Interface
影响因子:3.5
doi:10.1098/rsif.2008.0221
Dimelow, Richard J; Wilkinson, Stephen J
发表日期：2009
文献求助 收藏